Noteworthy Mentions

Eyong Ebai, Managing Director or Terumo Blood and Cell Technologies in Africa shares his insights on sickle cell disease and the IMARA framework launch in Kenya and Uganda.

Centralized manufacturing is not scalable for autologous cell therapies, but pure point-of-care models are not ready for scale.

Across the US, the UK, and parts of Europe, CGT progress is being held back by an inability to secure starting material supply, and not due to any sudden or unforeseeable crisis.

Antoinette Gawin discusses leadership, innovation in blood and cell therapy, and the global systems shaping access to advanced medicine

Cell and gene therapies are advancing quickly, but the systems needed to deliver them at scale are still lagging behind. Terumo’s new Ecosystem Blueprint aims to bridge that gap in Asia-Pacific

Liza Loidolt of Terumo Blood and Cell Technologies explains why starting material quality, standardised collection practices, and stronger ecosystem alignment are becoming critical to achieving consistent and scalable cell and gene therapy manufacturing.

Industrialization for CGT Scalability: Highlights From the Advanced Therapies USA Conference

As increasing numbers of advanced therapies move toward commercialization, blood centers are showing themselves to be essential partners in the endeavor, extending their established infrastructure into hospital networks and manufacturing workflows.

IBTV speaks with industry leaders at the 2025 Meeting on the Mesa to uncover the year’s defining breakthroughs

La Administración de Servicios Médicos de Puerto Rico (ASEM) y el Banco de Sangre de Puerto Rico en el Centro Médico anuncian la adopción del Sistema Automatizado ReveosTM y la Plataforma de Software LumiaTM de Terumo Blood and Cell Technologies (BCT)

Bridging Cell & Gene Therapy's Critical Skills Void

For CGTs, this will be the year where the rubber meets the road, according to industry thought leaders

Pacientes e especialistas defendem novas políticas e tecnologias para reduzir crises e ampliar cuidados perto de casa.

No ambulatório de hemoglobinopatias do Centro de Hematologia e Hemoterapia do Ceará (Hemoce), em Fortaleza, a rotina mudou desde agosto de 2023, quando foi instituída a troca automatizada de hemácias (aRBCx).

In a move set to ramp up healthcare services in East Africa, U.S based firm Terumo Blood and Cell Technologies, has invested in Kenya by officially inaugurating its new Africa headquarters and regional training center in Nairobi.

At a pivotal moment for sickle cell research and treatment, leading experts gather to debate the science, the clinical challenges, and the opportunities shaping tomorrow’s therapies.

This week, our conversations are with Wenyan Leong, director of APAC commercial and global strategic partnerships for cell and gene therapies at Terumo Blood and Cell Technologies, and Morten Graugaard, CEO of Orbis Medicines.